[Primary hypoaldosteronism and secondary pseudo-hypoaldosteronism]

Area of Science:

• Endocrinology
• Nephrology
• Internal Medicine

Background:

• Selective primary hypoaldosteronism is a rare endocrine disorder characterized by impaired aldosterone synthesis.
• Pseudohypoaldosteronism involves resistance to aldosterone's effects on the kidneys.
• Combined forms present diagnostic and therapeutic challenges.

Observation:

• A 23-year-old male presented with chronic hyperkalemia and hyponatremia, hypotension, and normal renal function.
• Biochemical tests revealed increased renin activity, low aldosterone, increased fractional sodium excretion, and decreased fractional potassium excretion.
• Initial treatment with fludrocortisone and sodium chloride failed to normalize electrolytes, suggesting a more complex condition.

Findings:

• The patient exhibited characteristics of both selective primary hypoaldosteronism (corticosterone methyl oxidase defect type II) and pseudohypoaldosteronism.
• Aldosterone infusion demonstrated impaired natriuretic and kaliuretic responses, consistent with pseudohypoaldosteronism.
• Combined therapy with low-dose fludrocortisone and sodium bicarbonate successfully corrected hyperkalemia and hyponatremia.

Implications:

• This case highlights the importance of considering combined aldosterone deficiency and resistance in patients with electrolyte imbalances.
• Successful management involved a tailored therapeutic approach addressing both aspects of the disorder.
• Understanding these complex interactions is crucial for effective treatment of rare endocrine-metabolic conditions.